Tower Research Capital (TRC)’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Tower Research Capital (TRC)’s Portfolio OCEA Stock Details OCEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,511	Closed	-$3.05K	–	5977
2024 Q4	$3.05K	Buy	5,511 +928	+20%	+$731	﹤0.01%	4724
2024 Q3	$4.49K	Sell	4,583 -5,603	-55%	-$6K	﹤0.01%	4528
2024 Q2	$12.4K	Buy	10,186 +2,143	+27%	+$3.66K	﹤0.01%	4029
2024 Q1	$30.4K	Sell	8,043 -11,249	-58%	-$21.1K	﹤0.01%	2641
2023 Q4	$12.7K	Buy	19,292 +6,771	+54%	+$9.29K	﹤0.01%	4022
2023 Q3	$48.8K	Buy	12,521 +12,190	+3,683%	+$56K	﹤0.01%	2567
2023 Q2	$1.99K	Sell	331 -7,298	-96%	-$42.8K	﹤0.01%	5280
2023 Q1	$51K	Buy	+7,629	New	+$64.5K	﹤0.01%	2484
2022 Q1	–	Sell	-13	Closed	–	–	6647
2021 Q4	$0	Buy	+13	New	+$130	﹤0.01%	6660

Other funds holding OCEA

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VPIM

Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

RWP

Revolve Wealth Partners Hackensack, New Jersey $965M AUM 22.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tower Research Capital (TRC)'s OCEA Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q1 2025, closing a stake of 5,511 shares — an estimated $3.05K sold.

Tower Research Capital (TRC) first reported a position in OCEA in Q4 2021 and held it in 9 quarters. The position peaked at $51K in Q1 2023. 25 funds tracked by Wall St. Rank hold OCEA as of Q1 2025.

Tower Research Capital (TRC) reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Tower Research Capital (TRC) sold 5,511 Ocean Biomedical, Inc. Common Stock shares in Q1 2025, an estimated $3.05K.
Tower Research Capital (TRC) first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
Tower Research Capital (TRC)'s Ocean Biomedical, Inc. Common Stock position peaked at $51K in Q1 2023.
25 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.